pegatron combination therapy
merck sharp & dohme (new zealand) limited - peginterferon alfa-2b 80ug; ribavirin 200mg; - combination - 200mg+80µg(clearclick) - active: peginterferon alfa-2b 80ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection active: ribavirin 200mg excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate tekprint blue sb-6018 titanium dioxide - pegatron combination therapy is indicated for the treatment of na?ve, relapse and non-responder patients with chronic hepatitis c (see clinical trials). patients must be 18 years of age or older and have compensated liver disease. pegatron combination therapy is also indicated for the treatment of patients with chronic hepatitis c who are co-infected with clinically stable hiv. interferon alfa monotherapy (including peg-intron) is indicated mainly in case of intolerance or contraindication to ribavirin. rebetol capsules must not be used alone because ribavirin is not effective as monotherapy in the treatment of hepatitis c. pegatron combination therapy is indicated for the treatment of chronic hepatitis c in children and adolescents with a bodyweight of nlt 27 kg with compensated liver disease and who have not received previous interferon treatment.
peg-intron
schering-plough a division of schering-plough animal health limited - peginterferon alfa-2b 80ug - powder for injection - 80 mcg - active: peginterferon alfa-2b 80ug excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polysorbate 80 sucrose water for injection
pegasys pre-filled syringe for injection 135 mcg0.5 ml
dksh singapore pte. ltd. - peginterferon alfa-2a - injection - 135 mcg/0.5 ml - peginterferon alfa-2a 135 mcg/0.5 ml
pegasys pre-filled syringe for injection 180 mcg0.5 ml
dksh singapore pte. ltd. - peginterferon alfa-2a - injection - 180 mcg/0.5 ml - peginterferon alfa-2a 180 mcg/0.5 ml
pegatron combination therapy peginterferon alfa-2b (rbe) 150 microgram powder for injection/capsule/diluent composite pack
merck sharp & dohme australia pty ltd - peginterferon alfa-2b,ribavirin -
pegatron combination therapy peginterferon alfa-2b (rbe) 120 microgram powder for injection/capsule/diluent composite pack
merck sharp & dohme australia pty ltd - peginterferon alfa-2b,ribavirin -
pegatron combination therapy peginterferon alfa-2b (rbe) 100 microgram powder for injection/capsule/diluent composite pack
merck sharp & dohme australia pty ltd - peginterferon alfa-2b,ribavirin -
pegatron combination therapy peginterferon alfa-2b (rbe) 80 microgram powder for injection/capsule/diluent composite pack
merck sharp & dohme australia pty ltd - peginterferon alfa-2b,ribavirin -
pegatron combination therapy peginterferon alfa-2b (rbe) 50 microgram powder for injection/capsule/diluent composite pack
merck sharp & dohme australia pty ltd - peginterferon alfa-2b,ribavirin -
pegetron capsule
merck canada inc - ribavirin; peginterferon alfa-2b - capsule - 200mg; 50mcg - ribavirin 200mg; peginterferon alfa-2b 50mcg - interferons